Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Consolidated Appropriations Act, 2022
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Issue related to tobacco industry and tobacco products, including the pending FDA rule on flavored cigars. Issues related to the regulation of synthetic nicotine, including H.R. 2471, the Consolidated Appropriations Act of 2022.
Consolidated Appropriations Act, 2022
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES via SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
2023 · first_quarter · Q1
Issues related to tobacco industry and tobacco products.
Issues related to tobacco industry and tobacco products.
Filing targets: HOUSE OF REPRESENTATIVES
Source: Senate LDA
Issue related to tobacco industry and tobacco products, including the pending FDA rule on flavored cigars. Issues related to the regulation of synthetic nicotine, including H.R. 2471, the Consolidated Appropriations Act of 2022.
American Rescue Plan Act of 2021
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 /Senate draft, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation including: -H.R. 1319, American Rescue Plan Act of 2021. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
American Rescue Plan Act of 2021
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 /Senate draft, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation including: -H.R. 1319, American Rescue Plan Act of 2021. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Tobacco Tax Equity Act of 2021
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Tobacco Tax Equity Act of 2021
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 /Senate draft, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation including: -H.R. 1319, American Rescue Plan Act of 2021. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Tobacco Tax Equity Act of 2021
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Tobacco Tax Equity Act of 2021
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Tobacco Tax Equity Act of 2021
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Tobacco Tax Equity Act of 2021
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 /Senate draft, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation including: -H.R. 1319, American Rescue Plan Act of 2021. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
MOMMA’s Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
MOMMA’s Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
MOMMA’s Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 /Senate draft, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation including: -H.R. 1319, American Rescue Plan Act of 2021. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
MOMMA’s Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 /Senate draft, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation including: -H.R. 1319, American Rescue Plan Act of 2021. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 /Senate draft, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation including: -H.R. 1319, American Rescue Plan Act of 2021. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 /Senate draft, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation including: -H.R. 1319, American Rescue Plan Act of 2021. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Inflation Reduction Act of 2022
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Monitored the Build Back Better Act (H.R. 5376) for implications on international trade and supply chain issues.
Inflation Reduction Act of 2022
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Inflation Reduction Act of 2022
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Inflation Reduction Act of 2022
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Inflation Reduction Act of 2022
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Tobacco Tax Equity Act of 2021
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Tobacco Tax Equity Act of 2021
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 /Senate draft, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation including: -H.R. 1319, American Rescue Plan Act of 2021. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Tobacco Tax Equity Act of 2021
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 /Senate draft, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation including: -H.R. 1319, American Rescue Plan Act of 2021. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Tobacco Tax Equity Act of 2021
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Tobacco Tax Equity Act of 2021
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Tobacco Tax Equity Act of 2021
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
MOMMA’s Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
MOMMA’s Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
MOMMA’s Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 /Senate draft, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation including: -H.R. 1319, American Rescue Plan Act of 2021. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
MOMMA’s Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 /Senate draft, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation including: -H.R. 1319, American Rescue Plan Act of 2021. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Consolidated Appropriations Act, 2021
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: H.R. 133, FY 2021 Omnibus and COVID Relief and Response Act. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Consolidated Appropriations Act, 2021
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: H.R. 133, FY 2021 Omnibus and COVID Relief and Response Act. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
SAFE Kids Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
SAFE Kids Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
SAFE Kids Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
SAFE Kids Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: H.R. 133, FY 2021 Omnibus and COVID Relief and Response Act. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: H.R. 133, FY 2021 Omnibus and COVID Relief and Response Act. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Tobacco to 21 Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Tobacco to 21 Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Youth Vaping Prevention Act of 2019
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Youth Vaping Prevention Act of 2019
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Youth Vaping Prevention Act of 2019
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Youth Vaping Prevention Act of 2019
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Preventing Online Sales of E-Cigarettes to Children Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: H.R. 133, FY 2021 Omnibus and COVID Relief and Response Act. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Preventing Online Sales of E-Cigarettes to Children Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Preventing Online Sales of E-Cigarettes to Children Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Preventing Online Sales of E-Cigarettes to Children Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: H.R. 133, FY 2021 Omnibus and COVID Relief and Response Act. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
QUITS Act of 2019
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
QUITS Act of 2019
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
QUITS Act of 2019
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
QUITS Act of 2019
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Protecting American Lungs Act of 2019
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Protecting American Lungs Act of 2019
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Protecting American Lungs Act of 2019
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Protecting American Lungs Act of 2019
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
The Heroes Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
The Heroes Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Preventing Online Sales of E-Cigarettes to Children Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: H.R. 133, FY 2021 Omnibus and COVID Relief and Response Act. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Preventing Online Sales of E-Cigarettes to Children Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Preventing Online Sales of E-Cigarettes to Children Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Preventing Online Sales of E-Cigarettes to Children Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: H.R. 133, FY 2021 Omnibus and COVID Relief and Response Act. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Tobacco to 21 Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Tobacco to 21 Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Tobacco-Free Youth Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Tobacco-Free Youth Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Tobacco-Free Youth Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Tobacco-Free Youth Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
E-Cigarette Tax Parity Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
E-Cigarette Tax Parity Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
E-Cigarette Tax Parity Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
E-Cigarette Tax Parity Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Tobacco Tax Equity Act of 2019
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Tobacco Tax Equity Act of 2019
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Tobacco Tax Equity Act of 2019
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Tobacco Tax Equity Act of 2019
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Reversing the Youth Tobacco Epidemic Act of 2020
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Reversing the Youth Tobacco Epidemic Act of 2020
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Reversing the Youth Tobacco Epidemic Act of 2020
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Reversing the Youth Tobacco Epidemic Act of 2020
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
SAFE Kids Act
Client: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES · Firm: SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
2022 · fourth_quarter · Q4
Issue related to tobacco industry and tobacco products.
Issue related to tobacco industry and tobacco products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES via SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
2022 · third_quarter · Q3
Issue related to tobacco industry and tobacco products, including the FDA rule on flavored cigars.
Issue related to tobacco industry and tobacco products, including the FDA rule on flavored cigars.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES via SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
2022 · second_quarter · Q2
Issue related to tobacco industry and tobacco products, including the FDA rule on flavored cigars.
Issue related to tobacco industry and tobacco products, including the FDA rule on flavored cigars.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES via SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
2022 · first_quarter · Q1
Issue related to tobacco industry and tobacco products, including the pending FDA rule on flavored cigars. Issues related to the regulation of synthetic nicotine, including H.R. 2471, the Consolidated Appropriations Act of 2022.
Issue related to tobacco industry and tobacco products, including the pending FDA rule on flavored cigars. Issues related to the regulation of synthetic nicotine, including H.R. 2471, the Consolidated Appropriations Act of 2022.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES via SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
2021 · fourth_quarter · Q4
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES via SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
2021 · third_quarter · Q3
Monitored the Build Back Better Act (H.R. 5376) for implications on international trade and supply chain issues.
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES via SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
2021 · second_quarter · Q2
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 /Senate draft, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation including: -H.R. 1319, American Rescue Plan Act of 2021. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES via SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
2021 · first_quarter · Q1
Outreach and monitoring related to the tobacco industry. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES via SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
2020 · fourth_quarter · Q4
Outreach and monitoring related to the tobacco industry. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: H.R. 133, FY 2021 Omnibus and COVID Relief and Response Act. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES via SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
2020 · third_quarter · Q3
Outreach and monitoring related to the tobacco industry. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES via SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
2020 · second_quarter · Q2
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES via SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
2020 · first_quarter · Q1
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES via SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
2019 · fourth_quarter · Q4
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1048 / H.R. 2111, Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction. S. 1253 / HR 3942, Preventing Online Sales of E-Cigarettes to Children Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 1895, Lower Health Care Costs Act, provisions related to tobacco control. S.2463, E-Cigarette Tax Parity Act. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2084, SCOTT Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 1865, FY 2020 Consolidated Appropriations Act; Agriculture and Health and Human Services Titles.
SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES via SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
2019 · third_quarter · Q3
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1048 / H.R. 2111, Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction. S. 1253 / HR 3942, Preventing Online Sales of E-Cigarettes to Children Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 1895, Lower Health Care Costs Act, provisions related to tobacco control. S.2463, E-Cigarette Tax Parity Act. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2084, SCOTT Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. S. 2522 / H.R. 3164, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020. H.R. 2740, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2020. Senate Draft Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2020.
SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES via SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
2019 · second_quarter · Q2
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541,Tobacco-Free Youth Act. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2084, SCOTT Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 3164, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020. Senate Draft Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020. H.R. 2740, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2020. Senate Draft Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2020.
SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES via SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
2019 · first_quarter · Q1
Congressional and Administrative outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019.
SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES via SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
2019 · first_quarter · RR
Administrative and legislative outreach and monitoring on issues related to the tobacco and vaping industries.
Administrative and legislative outreach and monitoring on issues related to the tobacco and vaping industries.
Administrative and legislative outreach and monitoring on issues related to the tobacco and vaping industries.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 /Senate draft, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation including: -H.R. 1319, American Rescue Plan Act of 2021. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Outreach and monitoring related to the tobacco industry. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Outreach and monitoring related to the tobacco industry. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: H.R. 133, FY 2021 Omnibus and COVID Relief and Response Act. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Outreach and monitoring related to the tobacco industry. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, tobacco 21, online sales bans, and tobacco product user fees. Outreach and monitoring regarding the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1048 / H.R. 2111, Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction. S. 1253 / HR 3942, Preventing Online Sales of E-Cigarettes to Children Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 1895, Lower Health Care Costs Act, provisions related to tobacco control. S.2463, E-Cigarette Tax Parity Act. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2084, SCOTT Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 1865, FY 2020 Consolidated Appropriations Act; Agriculture and Health and Human Services Titles.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1048 / H.R. 2111, Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction. S. 1253 / HR 3942, Preventing Online Sales of E-Cigarettes to Children Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541, Tobacco-Free Youth Act. S. 1895, Lower Health Care Costs Act, provisions related to tobacco control. S.2463, E-Cigarette Tax Parity Act. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2084, SCOTT Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. S. 2522 / H.R. 3164, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020. H.R. 2740, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2020. Senate Draft Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2020.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1258 / H.R. 2411, Tobacco to 21 Act. S. 1541,Tobacco-Free Youth Act. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2084, SCOTT Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 3164, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020. Senate Draft Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020. H.R. 2740, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2020. Senate Draft Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2020.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Congressional and Administrative outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor federal and legislative action related to the marketing and advertising of tobacco products. Outreach and monitoring related to FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) Outreach and monitoring related to FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) Outreach and monitoring related to S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Vice President of the U.S.